This document discusses the diagnostic approach to myopathies. It emphasizes that obtaining a comprehensive medical history is very important for diagnosis. The history should clarify the patient's symptoms, any family history of muscle disorders, precipitating factors, associated conditions, and distribution of weakness. Different myopathies are characterized by features like muscle pain, stiffness, weakness, or damage shown by myoglobinuria. Specific myopathies can be suggested based on the pattern of muscle involvement, such as proximal or distal weakness. The document provides tables matching myopathies to various clinical features to guide diagnosis.
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Myopathy
1. DR MOHAMMAD A.S KAMIL
CONSULTANT NEUROLOGIST
NEUROSCIENCES HOSPITAL
2. • MYOPATHIES ARE A HETEROGENEOUS GROUP OF DISORDERS THAT CAN BE
CHALLENGING TO DIAGNOSE.
• THE PURPOSE OF THIS REVIEW IS TO PROVIDE A DIAGNOSTIC APPROACH BASED
PREDOMINANTLY ON THE CLINICAL HISTORY AND NEUROLOGIC EXAMINATION.
• IN APPROACHING THE EVALUATION OF A PATIENT WITH A SUSPECTED
MYOPATHY, ONE OF THE MOST IMPORTANT COMPONENTS IS A COMPREHENSIVE
MEDICAL HISTORY.
5. Which ‘‘positive’’ and/or ‘‘negative’’ symptoms does the patient experience?
What is the temporal evolution (presentation,episodic,constant,acute)
Does the patient have a family history of a myopathic disorder?
Are there precipitating factors that trigger episodic weakness or stiffness (drugs,exercise,fever,high carbohydrate,cold)
Are any associated systemic symptoms or signs present (cardiac,respiratory,hepatomegaly,cataract,rash)
What is the distribution of weakness?
10. CAUSES OF MYOGLOBINURIAA
Drugs and toxins (especially alcohol)
Heatstroke
Inflammatory myopathies (rare)
Limb-girdle muscular dystrophy types 2C, 2D, 2E, and 2F (sarcoglycanopathies) and 2I (FKRP)
Neuroleptic malignant syndrome
Metabolic myopathies
Prolonged, intensive exercise
Severe metabolic disturbances, including prolonged fever
Trauma (crush injuries)
Viral and bacterial infections
11. DRUGS THAT CAN CAUSE TOXIC
MYOPATHIES
Inflammatory
• Cimetidine
• D-penicillamine
• Procainamide
• L-tryptophan
• Levodopa
Non inflammatory
Necrotizing or
Vacuolar
• Alcohol
• Cholesterol-lowering
agents
• Chloroquine
• Colchicine
• Cyclosporine and
tacrolimus
• Emetine
• (-aminocaproic acid
• Isoretinoic acid
(vitamin A analogue)
• Labetalol
• Vincristine
Rhabdomyolysis and
Myoglobinuria
• Alcohol
• Amphetamine
• Cholesterol-lowering
drugs
• Cocaine
• Heroin
• Toluene
• (-aminocaproic acid
Myosin Loss
• Non depolarizing
neuromuscular
blocking agents
• Steroid
12. Pattern
recognition
approach to
myopathy
Proximal Limb-Girdle
Distal Weakness
Distal Arm/Proximal Leg Weakness
Proximal Arm/Distal Leg (Scapuloperoneal) Weakness
Ptosis With or Without Ophthalmoparesis
Extensor Weakness Prominent Neck
Bulbar Weakness
Episodic pain,weakness and myoglobinurea
Episodic weakness delayed or unrelated to execise
stiffness and Decreased Ability to Relax
13. MYOPATHIES
CHARACTERIZED BY PREDOMINANTLY DISTAL
WEAKNESS
Centronuclear myopathy
Debrancher deficiency
Hereditary inclusion body myopathy
Inclusion body myositis
Myofibrillar myopathy
Myotonic dystrophy
Distal myopathies (Welander, Markes bery/Udd,Nonaka,Miyoshi,Liang)